Low-power laser irradiation suppresses inflammatory response of human adipose-derived stem cells by modulating intracellular cyclic AMP level and NF-κB activity

PLoS One. 2013;8(1):e54067. doi: 10.1371/journal.pone.0054067. Epub 2013 Jan 16.

Abstract

Mesenchymal stem cell (MSC)-based tissue regeneration is a promising therapeutic strategy for treating damaged tissues. However, the inflammatory microenvironment that exists at a local injury site might restrict reconstruction. Low-power laser irradiation (LPLI) has been widely applied to retard the inflammatory reaction. The purpose of this study was to investigate the anti-inflammatory effect of LPLI on human adipose-derived stem cells (hADSCs) in an inflammatory environment. We showed that the hADSCs expressed Toll-like Receptors (TLR) 1, TLR2, TLR3, TLR4, and TLR6 and that lipopolysaccharide (LPS) significantly induced the production of pro-inflammatory cytokines (Cyclooxygenase-2 (Cox-2), Interleukin-1β (IL-1β), Interleukin-6 (IL-6), and Interleukin-8 (IL-8)). LPLI markedly inhibited LPS-induced, pro-inflammatory cytokine expression at an optimal dose of 8 J/cm². The inhibitory effect triggered by LPLI might occur through an increase in the intracellular level of cyclic AMP (cAMP), which acts to down-regulate nuclear factor kappa B (NF-κB) transcriptional activity. These data collectively provide insight for further investigations of the potential application of anti-inflammatory treatment followed by stem cell therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / cytology*
  • Cell Line, Tumor
  • Cyclic AMP / metabolism*
  • Cyclooxygenase 2 / metabolism
  • Humans
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Lipopolysaccharides / pharmacology
  • Low-Level Light Therapy / adverse effects*
  • NF-kappa B / metabolism*
  • Stem Cells / cytology*
  • Stem Cells / drug effects
  • Stem Cells / radiation effects*

Substances

  • Interleukin-1beta
  • Interleukin-6
  • Interleukin-8
  • Lipopolysaccharides
  • NF-kappa B
  • Cyclic AMP
  • Cyclooxygenase 2

Grants and funding

This study was supported by a grant from the National Health Research Institutes (NHRI-EX101-9914EC), a grant from the Kaohsiung Municipal Ta-Tung Hospital (KMTTH-99-013), and a grant from the Kaohsiung Medical University (KMU-Q099018) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.